102 related articles for article (PubMed ID: 10706080)
21. Gene therapy with human recombinant osteoprotegerin reverses established osteopenia in ovariectomized mice.
Kostenuik PJ; Bolon B; Morony S; Daris M; Geng Z; Carter C; Sheng J
Bone; 2004 Apr; 34(4):656-64. PubMed ID: 15050896
[TBL] [Abstract][Full Text] [Related]
22. Osteoprotegerin is expressed in colon carcinoma cells.
Pettersen I; Bakkelund W; Smedsrød B; Sveinbjørnsson B
Anticancer Res; 2005; 25(6B):3809-16. PubMed ID: 16309167
[TBL] [Abstract][Full Text] [Related]
23. Osteoclastogenesis inhibitory factor exhibits hypocalcemic effects in normal mice and in hypercalcemic nude mice carrying tumors associated with humoral hypercalcemia of malignancy.
Akatsu T; Murakami T; Ono K; Nishikawa M; Tsuda E; Mochizuki SI; Fujise N; Higashio K; Motoyoshi K; Yamamoto M; Nagata N
Bone; 1998 Dec; 23(6):495-8. PubMed ID: 9855457
[TBL] [Abstract][Full Text] [Related]
24. Role of osteoprotegerin (OPG) in cancer.
Holen I; Shipman CM
Clin Sci (Lond); 2006 Mar; 110(3):279-91. PubMed ID: 16464170
[TBL] [Abstract][Full Text] [Related]
25. Regulation of secretion of osteoprotegerin in rat dental follicle cells.
Wise GE; Ding D; Yao S
Eur J Oral Sci; 2004 Oct; 112(5):439-44. PubMed ID: 15458504
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-1 receptor antagonist inhibits the hypercalcemia mediated by interleukin-1.
Guise TA; Garrett IR; Bonewald LF; Mundy GR
J Bone Miner Res; 1993 May; 8(5):583-7. PubMed ID: 8511985
[TBL] [Abstract][Full Text] [Related]
27. Osteoprotegerin and its ligand: A new paradigm for regulation of osteoclastogenesis and bone resorption.
Aubin JE; Bonnelye E
Medscape Womens Health; 2000 Mar; 5(2):5. PubMed ID: 10792853
[TBL] [Abstract][Full Text] [Related]
28. Prolonged decrease of serum calcium concentration by murine gamma-interferon in hypercalcemic, human tumor (EC-GI)-bearing nude mice.
Sato K; Satoh T; Shizume K; Yamakawa Y; Ono Y; Demura H; Akatsu T; Takahashi N; Suda T
Cancer Res; 1992 Jan; 52(2):444-9. PubMed ID: 1728416
[TBL] [Abstract][Full Text] [Related]
29. Osteoprotegerin in prostate cancer bone metastasis.
Corey E; Brown LG; Kiefer JA; Quinn JE; Pitts TE; Blair JM; Vessella RL
Cancer Res; 2005 Mar; 65(5):1710-8. PubMed ID: 15753366
[TBL] [Abstract][Full Text] [Related]
30. Osteoprotegerin/osteoclastogenesis inhibitory factor decreases human prostate cancer burden in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice.
Yonou H; Kanomata N; Goya M; Kamijo T; Yokose T; Hasebe T; Nagai K; Hatano T; Ogawa Y; Ochiai A
Cancer Res; 2003 May; 63(9):2096-102. PubMed ID: 12727825
[TBL] [Abstract][Full Text] [Related]
31. Chinese hamster ovarian cells transfected with human parathyroid hormone-related protein cDNA cause hypercalcemia in nude mice.
Guise TA; Chirgwin JM; Favarato G; Boyce BF; Mundy GR
Lab Invest; 1992 Oct; 67(4):477-85. PubMed ID: 1434529
[TBL] [Abstract][Full Text] [Related]
32. Thyroid hormone stimulates osteoclast differentiation by a mechanism independent of RANKL-RANK interaction.
Kanatani M; Sugimoto T; Sowa H; Kobayashi T; Kanzawa M; Chihara K
J Cell Physiol; 2004 Oct; 201(1):17-25. PubMed ID: 15281085
[TBL] [Abstract][Full Text] [Related]
33. Statins modulate the levels of osteoprotegerin/receptor activator of NFkappaB ligand mRNA in mouse bone-cell cultures.
Kaji H; Kanatani M; Sugimoto T; Chihara K
Horm Metab Res; 2005 Oct; 37(10):589-92. PubMed ID: 16278780
[TBL] [Abstract][Full Text] [Related]
34. TNF-alpha antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis.
Saidenberg-Kermanac'h N; Corrado A; Lemeiter D; deVernejoul MC; Boissier MC; Cohen-Solal ME
Bone; 2004 Nov; 35(5):1200-7. PubMed ID: 15542046
[TBL] [Abstract][Full Text] [Related]
35. Suppression of polyethylene particle-induced osteolysis by exogenous osteoprotegerin.
von Knoch F; Heckelei A; Wedemeyer C; Saxler G; Hilken G; Brankamp J; Sterner T; Landgraeber S; Henschke F; Löer F; von Knoch M
J Biomed Mater Res A; 2005 Nov; 75(2):288-94. PubMed ID: 16088891
[TBL] [Abstract][Full Text] [Related]
36. Increased production of tumor necrosis factor by normal immune cells in a model of the humoral hypercalcemia of malignancy.
Sabatini M; Yates AJ; Garrett IR; Chavez J; Dunn JF; Bonewald L; Mundy GR
Lab Invest; 1990 Nov; 63(5):676-82. PubMed ID: 2232714
[TBL] [Abstract][Full Text] [Related]
37. The effect of low calcium diet, mithramycin, and dichlorodimethylene bisphosphonate on humoral hypercalcemia of malignancy in nude mice transplanted with the canine adenocarcinoma tumor line (CAC-8).
Rosol TJ; Capen CC
J Bone Miner Res; 1987 Oct; 2(5):395-405. PubMed ID: 2971305
[TBL] [Abstract][Full Text] [Related]
38. Effects of parathyroid hormone (PTH)-related protein and PTH on osteoclasts and osteoclast precursors in vivo.
Uy HL; Guise TA; De La Mata J; Taylor SD; Story BM; Dallas MR; Boyce BF; Mundy GR; Roodman GD
Endocrinology; 1995 Aug; 136(8):3207-12. PubMed ID: 7628353
[TBL] [Abstract][Full Text] [Related]
39. Cinacalcet attenuates hypercalcemia observed in mice bearing either Rice H-500 Leydig cell or C26-DCT colon tumors.
Colloton M; Shatzen E; Wiemann B; Starnes C; Scully S; Henley C; Martin D
Eur J Pharmacol; 2013 Jul; 712(1-3):8-15. PubMed ID: 23623934
[TBL] [Abstract][Full Text] [Related]
40. Extracts of porcine pancreas prevent progression of hypercalcemia and cachexia and prolong survival in nude mice bearing a human squamous carcinoma.
Yoneda T; Takaoka Y; Boyce BF; Scott L; Mundy GR
Cancer Res; 1994 May; 54(9):2509-13. PubMed ID: 8162601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
